Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 May 2020
Historique:
received: 27 04 2020
accepted: 06 05 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 5 3 2021
Statut: epublish

Résumé

Although the genetic architecture of amyotrophic lateral sclerosis (ALS) is incompletely understood, recent findings suggest a complex model of inheritance in ALS, which is consistent with a multistep pathogenetic process. Therefore, the aim of our work is to further explore the architecture of ALS using targeted next generation sequencing (NGS) analysis, enriched in motor neuron diseases (MND)-associated genes which are also implicated in axonal hereditary motor neuropathy (HMN), in order to investigate if disease expression, including the progression rate, could be influenced by the combination of multiple rare gene variants. We analyzed 29 genes in an Italian cohort of 83 patients with both familial and sporadic ALS. Overall, we detected 43 rare variants in 17 different genes and found that 43.4% of the ALS patients harbored a variant in at least one of the investigated genes. Of note, 27.9% of the variants were identified in other MND- and HMN-associated genes. Moreover, multiple gene variants were identified in 17% of the patients. The burden of rare variants is associated with reduced survival and with the time to reach King stage 4, i.e., the time to reach the need for percutaneous endoscopic gastrostomy (PEG) positioning or non-invasive mechanical ventilation (NIMV) initiation, independently of known negative prognostic factors. Our data contribute to a better understanding of the molecular basis of ALS supporting the hypothesis that rare variant burden could play a role in the multistep model of disease and could exert a negative prognostic effect. Moreover, we further extend the genetic landscape of ALS to other MND-associated genes traditionally implicated in degenerative diseases of peripheral axons, such as HMN and CMT2.

Identifiants

pubmed: 32397312
pii: ijms21093346
doi: 10.3390/ijms21093346
pmc: PMC7246633
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Ministry of Health
ID : #RF-2011-02351193

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Neurobiol Aging. 2016 Jan;37:209.e9-209.e16
pubmed: 26601740
J Neurol. 2011 Jul;258(7):1234-9
pubmed: 21258814
Neurobiol Aging. 2017 Oct;58:238.e9-238.e15
pubmed: 28709720
Neurology. 2004 Aug 24;63(4):724-6
pubmed: 15326253
Neurology. 2011 Apr 26;76(17):1524-6
pubmed: 21519004
J Med Genet. 2010 Apr;47(4):249-56
pubmed: 19889647
Acta Neuropathol. 2014 Sep;128(3):397-410
pubmed: 24899140
BMC Med Genet. 2010 Mar 29;11:48
pubmed: 20350294
Amyotroph Lateral Scler. 2011 Mar;12(2):150-2
pubmed: 21247266
Neurogenetics. 2013 Feb;14(1):53-61
pubmed: 23129421
BMC Med Genet. 2006 Jun 08;7:53
pubmed: 16762064
Neuropediatrics. 2008 Dec;39(6):347-50
pubmed: 19569000
Front Mol Neurosci. 2017 Nov 09;10:370
pubmed: 29170628
Neurology. 2008 Apr 15;70(16 Pt 2):1384-9
pubmed: 18337587
Mol Genet Genomic Med. 2014 Nov;2(6):522-9
pubmed: 25614874
J Neurol. 2013 May;260(5):1286-94
pubmed: 23269439
Neurobiol Aging. 2017 Sep;57:206-219
pubmed: 28666709
J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):869-875
pubmed: 28822984
Hum Mol Genet. 2001 Mar 15;10(6):591-7
pubmed: 11230178
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Neurology. 2001 Feb 27;56(4):467-71
pubmed: 11222789
Int J Cell Biol. 2018 Sep 19;2018:5207608
pubmed: 30402103
Hum Mutat. 2009 Mar;30(3):E500-19
pubmed: 19105190
Eur J Hum Genet. 2017 Feb;25(3):324-331
pubmed: 28051077
Am J Hum Genet. 2013 Nov 7;93(5):900-5
pubmed: 24119685
Neurology. 2018 Aug 14;91(7):e635-e642
pubmed: 30045958
Hum Brain Mapp. 2015 Jul;36(7):2602-14
pubmed: 25821176
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1324-6
pubmed: 20861059
Neurobiol Aging. 2017 May;53:194.e1-194.e8
pubmed: 28160950
Lancet. 2017 Nov 4;390(10107):2084-2098
pubmed: 28552366
Lancet Neurol. 2014 Nov;13(11):1108-1113
pubmed: 25300936
Neuromuscul Disord. 2017 Jul;27(7):607-615
pubmed: 28554554
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol Sci. 2011 Jan 15;300(1-2):9-13
pubmed: 21084099
J Neurol. 2017 Jan;264(1):54-63
pubmed: 27778156
Nature. 2007 Jul 5;448(7149):68-72
pubmed: 17572665
Am J Hum Genet. 2011 Aug 12;89(2):308-12
pubmed: 21820100
Neurology. 2010 Feb 2;74(5):366-71
pubmed: 20124201
Front Neurosci. 2019 Jun 25;13:601
pubmed: 31293369
Hum Mutat. 2010 May;31(5):617-21
pubmed: 20186691
Front Mol Biosci. 2016 Dec 14;3:81
pubmed: 28018906
PLoS Genet. 2011 Jun;7(6):e1002104
pubmed: 21655088
Ann Neurol. 2011 Jan;69(1):197-201
pubmed: 21280090
Front Mol Neurosci. 2016 Oct 13;9:92
pubmed: 27790088
Biochemistry (Mosc). 2012 Dec;77(13):1500-14
pubmed: 23379525
Brain. 2014 Jul;137(Pt 7):1907-20
pubmed: 24833714
J Neurol Neurosurg Psychiatry. 2019 May;90(5):537-542
pubmed: 30355605
BMC Med Genet. 2015 Sep 21;16:84
pubmed: 26392352
Hum Mol Genet. 2012 Sep 1;21(17):3776-84
pubmed: 22645277
Neuromuscul Disord. 2014 Aug;24(8):666-70
pubmed: 24878229
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cell Cycle. 2010 Apr 15;9(8):1487-503
pubmed: 20404484
Brain. 2011 Jul;134(Pt 7):1959-71
pubmed: 21705420
Neurobiol Aging. 2015 Mar;36(3):1600.e5-8
pubmed: 25588603
Biomed Res Int. 2014;2014:210401
pubmed: 25025039
Brain. 2010 Feb;133(Pt 2):591-8
pubmed: 20110243
Clin Genet. 2013 Mar;83(3):257-62
pubmed: 22571692
Neurobiol Aging. 2012 May;33(5):1017.e17-23
pubmed: 22244934
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90
pubmed: 19710046
J Neurol Sci. 1997 Dec 9;153(1):46-9
pubmed: 9455977
Neurobiol Aging. 2015 May;36(5):2005.e15-22
pubmed: 25796131
Hum Mutat. 2014 Mar;35(3):298-302
pubmed: 24307404
Cell Biochem Biophys. 2012 Sep;64(1):61-72
pubmed: 22610661
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nat Genet. 2003 Apr;33(4):455-6
pubmed: 12627231
Brain. 2008 Mar;131(Pt 3):772-84
pubmed: 18079167
Brain. 2014 May;137(Pt 5):1323-36
pubmed: 24727571
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403
pubmed: 23292937
Lancet Neurol. 2018 May;17(5):423-433
pubmed: 29598923
Nat Neurosci. 2014 Jan;17(1):17-23
pubmed: 24369373
Cell Rep. 2017 Aug 29;20(9):2100-2115
pubmed: 28854361
J Med Genet. 2010 Mar;47(3):190-4
pubmed: 19861302
J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):536-41
pubmed: 1640227
J Med Genet. 2013 Nov;50(11):776-83
pubmed: 23881933
Neurobiol Aging. 2016 Mar;39:219.e1-8
pubmed: 26742954
Nat Genet. 2014 Dec;46(12):1264-6
pubmed: 25344691
J Neurol. 2016 Jun;263(6):1241-54
pubmed: 27025851
Lab Invest. 2019 Jul;99(7):993-1007
pubmed: 30742063
Brain. 2012 Oct;135(Pt 10):2980-93
pubmed: 23065789
Brain. 2017 Jun 1;140(6):1611-1618
pubmed: 28430856
Am J Hum Genet. 2009 Jan;84(1):85-8
pubmed: 19118816
Nat Genet. 2004 Jun;36(6):602-6
pubmed: 15122254
Neurology. 2010 Aug 10;75(6):539-46
pubmed: 20697106
Brain. 2009 Jan;132(Pt 1):8-15
pubmed: 18790819
Ann Neurol. 2015 Jan;77(1):100-13
pubmed: 25382069
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Eur J Hum Genet. 2017 Nov;25(11):1217-1228
pubmed: 28832565
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):740-6
pubmed: 21402743
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590

Auteurs

Stefania Scarlino (S)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Teuta Domi (T)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Laura Pozzi (L)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Alessandro Romano (A)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Giovanni Battista Pipitone (GB)

Laboratory of Clinical Molecular Biology, Unit of Genomics for human disease diagnosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy.

Yuri Matteo Falzone (YM)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.
Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.

Lorena Mosca (L)

Medical Genetic Unit, Department of Laboratory Medicine, Niguarda Hospital, 20132 Milan, Italy.

Silvana Penco (S)

Medical Genetic Unit, Department of Laboratory Medicine, Niguarda Hospital, 20132 Milan, Italy.

Christian Lunetta (C)

NEuroMuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan 20132, Italy.

Valeria Sansone (V)

NEuroMuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan 20132, Italy.
Department Biomedical Sciences of Health, University of Milan, 20132 Milan, Italy.

Lucio Tremolizzo (L)

Neurology Unit, "San Gerardo" Hospital and University of Milano-Bicocca, 20900 Monza, Italy.

Raffaella Fazio (R)

Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.

Federica Agosta (F)

Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Massimo Filippi (M)

Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.
Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Vita-Salute San Raffaele University,20132 Milan, Italy.

Paola Carrera (P)

Laboratory of Clinical Molecular Biology, Unit of Genomics for human disease diagnosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy.

Nilo Riva (N)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.
Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.

Angelo Quattrini (A)

Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH